Analysed ASPIRE BIOPHARMA HOLDINGS IN (ASBP:NASDAQ) News Sources
Aspire Biopharma's Buzz Bomb Caffeine Company Partners with Interwest Brokerage to Accelerate Retail Expansion
15-04-2026
yahoo.com
Aspire Biopharma Has Entered Into a Letter of Intent to Acquire a Leading Global Automotive Supplier With a 100+ Year History and $200M+ in 2025 Revenue
16-04-2026
yahoo.com
Aspire Biopharma's Buzz Bomb(TM) Caffeine Company's Brand Ambassador, Ashley Paulson, to Attempt Fastest 100-Mile Treadmill Run at 2026 Boston Marathon Expo
17-04-2026
yahoo.com
Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition
20-04-2026
yahoo.com
ASBP: A Platform Approach to Drug Delivery with an Unconventional Path to Commercialization
30-04-2026
yahoo.com
Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio
07-05-2026
yahoo.com
Aspire Biopharma's BUZZ BOMBTM Partners with EoS Fitness to Empower High-Performance Lifestyles for Millions of Members
27-05-2026
yahoo.com
What is the current price of ASPIRE BIOPHARMA HOLDINGS IN (ASBP:NASDAQ)?
The current price of ASPIRE BIOPHARMA HOLDINGS IN (ASBP:NASDAQ) is $5.87.
ASPIRE BIOPHARMA HOLDINGS IN (ASBP:NASDAQ) absolute price change since previous trading day?
The absolute price change of ASPIRE BIOPHARMA HOLDINGS IN (ASBP:NASDAQ) since the previous trading day is $0.38.
ASPIRE BIOPHARMA HOLDINGS IN (ASBP:NASDAQ) percentage price change since previous trading day?
The percentage price change of ASPIRE BIOPHARMA HOLDINGS IN (ASBP:NASDAQ) since the previous trading day is 6.9217%.
What is the most recent average sentiment score for ASPIRE BIOPHARMA HOLDINGS IN (ASBP:NASDAQ)?
The most recent average sentiment score for ASPIRE BIOPHARMA HOLDINGS IN (ASBP:NASDAQ) is 85 out of 100.
What is the most recent average sentiment for ASPIRE BIOPHARMA HOLDINGS IN (ASBP:NASDAQ)?
The most recent sentiment for ASPIRE BIOPHARMA HOLDINGS IN (ASBP:NASDAQ) is .
SEC-8K** Filing Available For ASPIRE BIOPHARMA HOLDINGS IN (ASBP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.